Microbiota and cancer immunotherapy: In search of microbial signals

Gut

Volumn 68, Issue 3, 2019, Pages 385-388

  Gharaibeh, Raad Z ^a   Jobin, Christian ^a,b  

^a UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF FLORIDA   (United States)

Author keywords

analysis; cancer; immunotherapy; metagenome; microbiota; PD 1

Indexed keywords

CANCER VACCINE; DNA 16S; PROGRAMMED DEATH 1 LIGAND 1; PROGRAMMED DEATH 1 RECEPTOR; PDCD1 PROTEIN, HUMAN;

AKKERMANSIA MUCINIPHILA; ARTICLE; BIFIDOBACTERIUM LONGUM; CANCER IMMUNOTHERAPY; CANCER RESEARCH; CHIMERIC ANTIGEN RECEPTOR IMMUNOTHERAPY; DRUG TARGETING; FAECALIBACTERIUM PRAUSNITZII; HUMAN; INTESTINE FLORA; METABOLOMICS; METAGENOME; METASTATIC MELANOMA; MICROBIAL COMMUNITY; MICROBIAL GENE; NON SMALL CELL LUNG CANCER; NONHUMAN; ONCOLYTIC VIROTHERAPY; POPULATION ABUNDANCE; PRIORITY JOURNAL; RENAL CELL CARCINOMA; SIGNAL TRANSDUCTION; SPECIES COMPOSITION; TREATMENT RESPONSE; IMMUNOLOGY; IMMUNOTHERAPY; INTESTINE; MICROBIOLOGY; NEOPLASM; PROCEDURES;

GASTROINTESTINAL MICROBIOME; HOST MICROBIAL INTERACTIONS; HUMANS; IMMUNOTHERAPY; INTESTINES; METAGENOME; NEOPLASMS; PROGRAMMED CELL DEATH 1 RECEPTOR;

EID: 85058263820     PISSN: 00175749     EISSN: 14683288     Source Type: Journal    
DOI: 10.1136/gutjnl-2018-317220     Document Type: Article

References (31)

1. Shreiner AB, Kao JY, Young VB. The gut microbiome in health and in disease. Curr Opin Gastroenterol 2015;31:69-75. doi:10.1097/MOG.0000000000000139
2. Nakatsu G, Zhou H, Wu WKK, et al. Alterations in enteric virome are associated with colorectal cancer and survival outcomes. Gastroenterology 2018;155:529-41. doi:10.1053/j.gastro.2018.04.018
3. Norman JM, Handley SA, Baldridge MT, et al. Disease-specific alterations in the enteric virome in inflammatory bowel disease. Cell 2015;160:447-60. doi:10.1016/j.cell.2015.01.002
4. Sokol H, Leducq V, Aschard H, et al. Fungal microbiota dysbiosis in IBD. Gut 2017;66:1039-48. doi:10.1136/gutjnl-2015-310746
5. Kelly CR, Kahn S, Kashyap P, et al. Update on fecal microbiota transplantation 2015: indications, methodologies, mechanisms, and outlook. Gastroenterology 2015;149:223-37. doi:10.1053/j.gastro.2015.05.008
6. Wallace BD, Wang H, Lane KT, et al. Alleviating cancer drug toxicity by inhibiting a bacterial enzyme. Science 2010;330:831-5. doi:10.1126/science.1191175
7. Geller LT, Barzily-Rokni M, Danino T, et al. Potential role of intratumor bacteria in mediating tumor resistance to the chemotherapeutic drug gemcitabine. Science 2017;357:1156-60. doi:10.1126/science.aah5043
8. Alexander JL, Wilson ID, Teare J, et al. Gut microbiota modulation of chemotherapy efficacy and toxicity. Nat Rev Gastroenterol Hepatol 2017;14:356-65. doi:10.1038/nrgastro.2017.20
9. Currò D. The role of gut microbiota in the modulation of drug action: a focus on some clinically significant issues. Expert Rev Clin Pharmacol 2018;11:171-83. doi:10.1080/17512433.2018.1414598
10. Koppel N, Maini Rekdal V, Balskus EP. Chemical transformation of xenobiotics by the human gut microbiota. Science 2017;356:eaag2770. doi:10.1126/science.aag2770
11. Routy B, Gopalakrishnan V, Daillère R, et al. The gut microbiota influences anticancer immunosurveillance and general health. Nat Rev Clin Oncol 2018;15:382-96. doi:10.1038/s41571-018-0006-2
12. Routy B, Le Chatelier E, Derosa L, et al. Gut microbiome influences efficacy of PD-1-based immunotherapy against epithelial tumors. Science 2018;359:91-7. doi:10.1126/science.aan3706
13. Gopalakrishnan V, Spencer CN, Nezi L, et al. Gut microbiome modulates response to anti-PD-1 immunotherapy in melanoma patients. Science 2018;359:97-103. doi:10.1126/science.aan4236
14. Matson V, Fessler J, Bao R, et al. The commensal microbiome is associated with anti-PD-1 efficacy in metastatic melanoma patients. Science 2018;359:104-8. doi:10.1126/science.aao3290
15. Zitvogel L, Ayyoub M, Routy B, et al. Microbiome and anticancer immunosurveillance. Cell 2016;165:276-87. doi:10.1016/j.cell.2016.03.001
16. Caporaso JG, Kuczynski J, Stombaugh J, et al. QIIME allows analysis of high-throughput community sequencing data. Nat Methods 2010;7:335-6. doi:10.1038/nmeth.f.303
17. Truong DT, Franzosa EA, Tickle TL, et al. MetaPhlAn2 for enhanced metagenomic taxonomic profiling. Nat Methods 2015;12:902-3. doi:10.1038/nmeth.3589
18. Segata N, Izard J, Waldron L, et al. Metagenomic biomarker discovery and explanation. Genome Biol 2011;12:R60. doi:10.1186/gb-2011-12-6-r60
19. DeSantis TZ, Hugenholtz P, Larsen N, et al. Greengenes, a chimera-checked 16S rRNA gene database and workbench compatible with ARB. Appl Environ Microbiol 2006;72:5069-72. doi:10.1128/AEM.03006-05
20. McDonald D, Price MN, Goodrich J, et al. An improved Greengenes taxonomy with explicit ranks for ecological and evolutionary analyses of bacteria and archaea. Isme J 2012;6:610-8. doi:10.1038/ismej.2011.139
21. Buchfink B, Xie C, Huson DH. Fast and sensitive protein alignment using DIAMOND. Nat Methods 2015;12:59-60. doi:10.1038/nmeth.3176
22. Kanehisa M, Goto S. KEGG: kyoto encyclopedia of genes and genomes. Nucleic Acids Res 2000;28:27-30. doi:10.1093/nar/28.1.27
23. Tibshirani R. Regression shrinkage and selection via the lasso. J R Stat Soc Series B, Stat Methodol 1996;58:267-88.
24. Tk H. Random Decision Forests. In: Proceedings of the third international conference on document analysis and recognition. Washington, DC, USA: IEEE Computer Society, 1995:278.
25. Cortes C, Vapnik V. Support-vector networks. Mach Learn 1995;20:273-97. doi:10.1007/BF00994018
26. Pasolli E, Truong DT, Malik F, et al. Machine learning meta-analysis of large metagenomic datasets: tools and biological insights. PLoS Comput Biol 2016;12:e1004977. doi:10.1371/journal.pcbi.1004977
27. Sinha R, Abu-Ali G, Vogtmann E, et al. Assessment of variation in microbial community amplicon sequencing by the Microbiome Quality Control (MBQC) project consortium. Nat Biotechnol 2017;35:1077-86. doi:10.1038/nbt.3981
28. do Carmo FLR, Rabah H, De Oliveira Carvalho RD, et al. Extractable bacterial surface proteins in probiotic-host interaction. Front Microbiol 2018;9:645. doi:10.3389/fmicb.2018.00645
29. Tang J, Shalabi A, Hubbard-Lucey VM. Comprehensive analysis of the clinical immuno-oncology landscape. Ann Oncol 2018;29:84-91. doi:10.1093/annonc/mdx755
30. Underhill DM, Iliev ID. The mycobiota: interactions between commensal fungi and the host immune system. Nat Rev Immunol 2014;14:405-16. doi:10.1038/nri3684
31. Neil JA, Cadwell K. The intestinal virome and immunity. J Immunol 2018;201:1615-24. doi:10.4049/jimmunol.1800631